Products- Robust titanium funnel
- Soft and lightweight silicone body
- 9.6 F ChronoFlex® Catheter
- IV access
- Unique valve technology
- Needle stop
- High-flow, Power-injectable1
-
United States
North America
South America
Europe
Middle East / Africa
Asia / Pacific
-
Login
Support
Sales
1.844.8.BD.LIFE (1.844.823.5433)
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
Ordering
1.714.283.2228
5 a.m. to 4 p.m. PT
1.714.283.8424
oem@carefusion.com
Customer Service
1.844.8.BD.LIFE (1.844.823.5433)
1.800.847.2220
PowerFlow™ Implantable Apheresis
IV Port
Designed for long device life, maximum flow, and patient comfort.
- Overview
- Products & Accessories
- EIFU & Resources
PowerFlow™ Implantable Apheresis IV Port
true
Optimized for Long Device Life
Bench tested up to 1,000 accesses2
Engineered for Maximum Flow
Large inner diameter polyurethane port catheter
Engineered for Patient Comfort
Totally Implantable to help address patient lifestyle
Bench Tested for High Flow Performance
Unique design and access delivers flow rates up to 150mL/min3 at low pressure
Designed for Easy Access
Access is performed at a shallow angle by percutaneous insertion of an over-the-needle soft peripheral intravenous catheter
The PowerFlow™ Implantable Apheresis IV Port is a high-flow, power-injectable port designed and indicated specifically for therapeutic apheresis. The PowerFlow™ Implantable Apheresis IV Port is designed for long device life, maximum flow, and patient comfort.
1. Power injectable up to 5mL/s @ 300 psi
2. After 1000 IV catheter insertions, bench top leak testing was performed both with the device accessed (both 14G and 16G IV catheters tested separately) and with no IV catheter present. Bench testing may not be indicative of actual clinical performance. Different test methods may yield different results. Data on file, Bard Peripheral Vascular, Inc., Tempe, Arizona.
3. Mean flow rates, 25 cm catheter, when tested in a benchtop model using a blood simulant with viscosity of 3.5cP, N=27. Simulated testing may not be indicative of actual clinical performance. Changes in blood viscosity, catheter length, and IV type will affect achievable flow rates.
Please consult Instructions for Use for product indications for use, contraindications, warnings, precautions, complications, adverse events and detailed safety information.
true
BD-23557
-
PowerFlow™ Implantable Apheresis IV Port
1. Power injectable up to 5mL/s @ 300 psi
2. After 1000 IV catheter insertions, bench top leak testing was performed both with the device accessed (both 14G and 16G IV catheters tested separately) and with no IV catheter present. Bench testing may not be indicative of actual clinical performance. Different test methods may yield different results. Data on file, Bard Peripheral Vascular, Inc., Tempe, Arizona.
3. Mean flow rates, 25 cm catheter, when tested in a benchtop model using a blood simulant with viscosity of 3.5cP, N=27. Simulated testing may not be indicative of actual clinical performance. Changes in blood viscosity, catheter length, and IV type will affect achievable flow rates.
Please consult Instructions for Use for product indications for use, contraindications, warnings, precautions, complications, adverse events and detailed safety information.
true
BD-23557
Literature
BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.
Learn more
Training
BD offers training resources to help improve your clinical practices as part of our goal of advancing the world of health.
Learn more
Events
BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.
Learn more
Case Studies
BD promotes clinical excellence by providing various resources on best practices, clinical innovations and industry trends in healthcare.
Learn more
1. Power injectable up to 5mL/s @ 300 psi
2. After 1000 IV catheter insertions, bench top leak testing was performed both with the device accessed (both 14G and 16G IV catheters tested separately) and with no IV catheter present. Bench testing may not be indicative of actual clinical performance. Different test methods may yield different results. Data on file, Bard Peripheral Vascular, Inc., Tempe, Arizona.
3. Mean flow rates, 25 cm catheter, when tested in a benchtop model using a blood simulant with viscosity of 3.5cP, N=27. Simulated testing may not be indicative of actual clinical performance. Changes in blood viscosity, catheter length, and IV type will affect achievable flow rates.
Please consult Instructions for Use for product indications for use, contraindications, warnings, precautions, complications, adverse events and detailed safety information.
true
BD-23557